ESMO 2023 Lung Cancer – Sebastian Kobold

Sebastian Kobold discusses the growing interest in using CAR-T cell therapy as an innovative approach to treat solid tumors in the future, as well as T cell receptor T cell therapy. Although there are still some hurdles to overcome, he discusses what remarkable developments can be expected in this field in the coming years.

Here is the full ESMO 2023 Lung Cancer report.